Clinical Trial Update: Combining Epigenetic And Immune Therapy to Beat Cancer. [Phase 2]

View source ↗

Summary

A Phase 2 trial from Institut Bergonié evaluating a combination of epigenetic therapy and immunotherapy in several advanced cancers has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer
• Pancreatic Cancer
• Soft Tissue Sarcoma
• Solid Tumors

Snippet

Sponsor: Institut Bergonié | Conditions: Advanced Solid Tumor, Advanced Colorectal Carcinoma | Phase 2 | Status: COMPLETED